Department of Radiology, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Department of Radiology, SMG-SNU Boramae Medical Center, Seoul 07061, Korea.
Korean J Radiol. 2018 May-Jun;19(3):508-515. doi: 10.3348/kjr.2018.19.3.508. Epub 2018 Apr 6.
To determine if measurement of the diameter of the solid component in subsolid nodules (SSNs) on low-dose unenhanced chest computed tomography (CT) is as accurate as on standard-dose enhanced CT in prediction of pathological size of invasive component of lung adenocarcinoma.
From February 2012 to October 2015, 114 SSNs were identified in 105 patients that underwent low-dose unenhanced and standard-dose enhanced CT pre-operatively. Three radiologists independently measured the largest diameter of the solid component. Intraclass correlation coefficients (ICCs) were used to assess inter-reader agreement. We estimated measurement differences between the size of solid component and that of invasive component. We measured diagnostic accuracy of the prediction of invasive adenocarcinoma using a size criterion of a solid component ≥ 6 mm, and compared them using a generalized linear mixed model.
Inter-reader agreement was excellent (ICC, 0.84.0.89). The mean ± standard deviation of absolute measurement differences between the solid component and invasive component was 4 ± 4 mm in low-dose unenhanced CT and 5 ± 4 mm in standard-dose enhanced CT. Diagnostic accuracy was 81.3% (95% confidence interval, 76.7.85.3%) in low-dose unenhanced CT and 76.6% (71.8.81.0%) in standard-dose enhanced CT, with no statistically significant difference ( = 0.130).
Measurement of the diameter of the solid component of SSNs on low-dose unenhanced chest CT was as accurate as on standard-dose enhanced CT for predicting the invasive component. Thus, low-dose unenhanced CT may be used safely in the evaluation of patients with SSNs.
在预测肺腺癌浸润成分的病理大小方面,确定低剂量平扫胸部 CT 测量亚实性结节(SSN)实性成分直径与标准剂量增强 CT 相比是否同样准确。
从 2012 年 2 月至 2015 年 10 月,对 105 例接受低剂量平扫和标准剂量增强 CT 术前检查的患者中发现的 114 个 SSN 进行了研究。三位放射科医生独立测量了实性成分的最大直径。采用组内相关系数(ICC)评估了读者间的一致性。我们估计了实性成分大小与浸润性成分大小之间的测量差异。我们使用实性成分≥6mm 的大小标准来预测浸润性腺癌,并使用广义线性混合模型进行比较。
读者间的一致性极好(ICC,0.84.0.89)。低剂量平扫 CT 中实性成分与浸润性成分的绝对测量差异的平均值±标准差为 4±4mm,标准剂量增强 CT 为 5±4mm。低剂量平扫 CT 的诊断准确率为 81.3%(95%置信区间,76.7.85.3%),标准剂量增强 CT 为 76.6%(71.8.81.0%),差异无统计学意义( = 0.130)。
低剂量平扫胸部 CT 测量 SSN 实性成分的直径与标准剂量增强 CT 一样准确,可用于预测浸润成分。因此,低剂量平扫 CT 可安全地用于评估 SSN 患者。